Chicago, IL (PRWEB) April 01, 2014
The birth control safety center DrugNews.net is alerting women who have taken the oral contraceptives Yaz or Yasmin of updated legal news on the site. The most recent court records indicate the number of lawsuits alleging blood clot side effects dropped for the month of March*.
DrugNews is a free resource for patients taking popular prescription drugs. By providing the latest product recalls, safety alerts, research and litigation news, visitors can recognize potential dangers, see if others are experiencing similar side effects and decide if they need legal advice.
The birth control center has added health warnings from authorities like the FDA** and British Medical Journal*** that birth control containing drospirenone, like Yaz and Yasmin, can increase the risk of blood clots. The U.K.’s Medicines and Healthcare Products Regulatory Agency also recently warned certain meds like Yasmin can double the risk of blood clots****.
A number of patients have filed a Yaz lawsuit alleging side effects, leading cases to be consolidated in a special federal court (Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100, Southern District Illinois)).
Now, DrugNews has learned the number of pending cases has fallen over 1% for the month of March, from 9,687 in February to 9,550 on March 13th*. Bayer has spent $1.69 billion so far to settle around 8,250 Yaz lawsuits alleging blood clot injuries like pulmonary embolism or deep vein thrombosis (DVT)*****.
Bayer says they will continue to evaluate new cases for settlement***** and lawyers are still helping those affected.
Anyone who suffered a blood clot, DVT, stroke or pulmonary embolism after taking Yaz or Yasmin is urged to visit DrugNews or speak with a lawyer about their legal options. DrugNews only recommends lawyers who have settled hundreds of Yaz lawsuits.
For more information on the research, side effects and litigation news related to Yaz and other drugs, or to speak with a lawyer, visit http://www.DrugNews.net.
*JPML, 3/13/14; jpml.uscourts.gov/sites/jpml/files/Pending_MDL_Dockets_By_District-March-13-2014.pdf
**FDA, 10/27/11, http://www.fda.gov/downloads/Drugs/DrugSafety/UCM277384.pdf
***BMJ, 10/25/11; ncbi.nlm.nih.gov/pubmed/22027398
****British Journal of Family Medicine, Feb 2014; bjfm.co.uk/content/article.aspx?id=25769806997
*****Bayer Annual Report, Notes to Consolidated Financial Statement, Legal Risks, 2/28/14; annualreport2013.bayer.com/en/legal-risks.aspx